Alexandros is an Editor for the BMC Series and the Editor of BMC Clinical Pathology since September 2017. Before joining BioMed Central, Alexandros completed his PhD in biomedical engineering at Imperial College London, UK and then worked for The Boston Consulting Group as a strategy consultant. Alexandros’ interests were shaped early on during his undergraduate studies, through his work on trans-cranial magnetic stimulation, which developed his passion for medical devices. During his PhD, his main research focus was the development of bio-inspired electronic solutions to treat prominent diseases and disorders, ranging from endocrine gland dysfunctions to skin inflammation. He concurrently worked on pro-bono consulting projects on a range of industries, including the synthetic biology industry. Alexandros is also a contributor to the BioMed Central blog network.
Rui Henrique received his MD from the Abel Salazar Institute of Biomedical Sciences of the University of Porto (ICBAS-UP) in 1992. In 2001, after completing a residency in Anatomic Pathology at the Portuguese Oncology Institute of Porto (IPO-Porto), subspecializing in Hematopathology and Uropathology, he became an attending pathologist. In 2006 he became Director of the Department of Pathology. He received his Ph.D. in Medical Sciences (Molecular Pathology) from ICBAS-UP (2006), in cooperation with Johns Hopkins University, USA. In 2011, he obtained the academical title of “Aggregate” in Pathology and Molecular Genetics (ICBAS-UP). He is an invited Full Professor of Pathology and Oncobiology at ICBAS-UP. His research interests focus on the characterization of epigenetic alterations in urological cancer and their translation into novel cancer biomarkers. He has authored and co-authored more than 170 publications in international peer-reviewed scientific periodicals. He joined the Editorial Board of BMC Clinical Pathology in 2014.
Ferdinando Mannello received a degree in Biology in 1982 and a specialization in Clinical Biochemistry in 1999 at the University “Carlo Bo” of Urbino. He completed fellowships in the USA (2005-9) and in the UK (2010). Since 2015, he has been Associate Professor of Clinical Biochemistry and Director of Clinical Biochemistry and Molecular Genetics at the Department of Biomolecular Sciences at the University of Urbino. He is also the chair of Clinical Biochemistry at the School of Biotechnology. His work focuses on clinical translational research of disease biomarkers. Since 2015, he has been responsible for the Biomolecular Diagnostic Committee of the Italian Society of Vascular Diagnostics (SIDV). He has authored over 140 papers as well as book chapters and has been invited to lecture at several international conferences. He has served on the board of BMC Clinical Pathology since 2013.